Introduction The coronavirus disease (COVID-19) is a global health emergency. Major
disruption to healthcare services during the current COVID-19 pandemic will last even after its …

Background The International Federation of Gynecology and Obstetrics (FIGO) systems for
nomenclature of symptoms of normal and abnormal uterine bleeding (AUB) in the …

BACKGROUND: The objective of this multicentre randomized, controlled clinical trial was to
compare the efficacy of a levonorgestrel-releasing intrauterine system (LNG-IUS) and a …

The objectives of this study were to evaluate the bleeding patterns and clinical performance
during the first 2 years of use of an intrauterine system releasing 20 μg/day of levonorgestrel …

Aim. The aim of the study is to compare the prevalence of depression in women surgically
diagnosed with endometriosis according to the presence or absence of pelvic pain. Methods. …

BACKGROUND: This study was conducted to evaluate the effect of the levonorgestrel-releasing
intrauterine system (LNG-IUS) on adenomyotic lesions diagnosed and monitored by …

BACKGROUND Most contraceptive methods present benefits beyond contraception;
however, despite a large body of evidence, many healthcare professionals (HCPs), users and …

En esta investigación se examina cómo los jóvenes de colegios católicos conciben su
relación con la Iglesia y los asuntos de la fe. Se muestra cómo, si bien perviven ciertas formas …

STUDY QUESTION Is there any difference in the clinical performance of the 3-year one-rod
etonogestrel (ENG)- and the 5-year two-rod levonorgestrel (LNG)-releasing contraceptive …

OBJECTIVES: This report is a review of the medical literature on the use of the
levonorgestrel-releasing intrauterine system (LNG-IUS®) in women with endometriosis, …